Genetic Editing for Healthcare

Advances in Disease Management

Inbunden, Engelska, 2026

AvBhupinder Singh,Rishabha Malviya,Sahil Lal,Sathvik Belagodu Sridhar

2 209 kr

Kommande

This book presents a focused and timely exploration of genome editing and its transformative impact on modern medicine. Integrating interdisciplinary perspectives, the volume examines how emerging genetic technologies are reshaping the prevention, diagnosis, and treatment of complex diseases.The book outlines the molecular foundations of key genome-editing tools, including CRISPRCas9, TALENs, and zinc-finger nucleases, explaining their mechanisms and expanding role in biomedical research. It then moves to practical applications, highlighting case studies in areas such as cancer treatment and precision medicine, demonstrating how gene-editing technologies are improving patient outcomes.Beyond technical advances, the volume addresses critical ethical, legal, and regulatory considerations, including biosafety, intellectual property, and human rights. By examining both opportunities and challenges, it emphasizes the need for responsible and well-regulated implementation of genetic technologies.Bringing together current research and applied insights, this volume offers a clear and balanced perspective on the evolving role of genome editing in advancing healthcare worldwide.

Produktinformation

Utgivningsdatum2026-08-18
Mått152 x 229 x undefined mm
FormatInbunden
SpråkEngelska
Antal sidor250
FörlagApple Academic Press Inc.
ISBN9781779643810

Tillhör följande kategorier

Medicinsk genetik inom Medicin
Biomedicinsk teknik inom Medicin

Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at the University of South Wales, UK. He has over 16 years of experience and has authored numerous publications and conference presentations across law and emerging technologies.Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with expertise in pharmaceutics and drug delivery. He has published over 200 papers, holds multiple patents, and is listed among the world’s Top 2% Scientists per Stanford University.Sahil Lal, PhD, is Assistant Professor of Law at Galgotias University, India. His work focuses on intellectual property and emerging technologies, particularly artificial intelligence and innovation policy.Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and Health Sciences University, UAE, with over 25 years of experience in clinical pharmacy and pharmacovigilance research.

1. Gene Editing Governance and Genetic Engineering: A Framework for Regulating CRISPR Technology 2. Application and Challenges of the CRISPR/Cas9 System for Gene Editing 3. Impact of Genomics on Drug Discovery and Clinical Medicine on Public Healthcare: Fostering Disease Prevention and Enhancing Human Well-Being. 4. Challenges and Approaches to Human Genome Editing 5. Precision Medicine Through Gene Editing: Pharmacogenomics and the Future of Disease Management in Clinical Healthcare 6. Patenting the Genome: A Global Perspective of Intellectual Property Rights and Genetic Innovation 7. Biosafety Issues Relating to Genome Editing in Plants and its Impact on Human Health 8. Gene Editing and Human Rights: Legal Implications of CRISPR Technology 9. Genomic Innovations in Drug Discovery and Clinical Medicine 10. Impact of Genomics on Drug Discovery and Clinical Medicine: Fostering Gene Editing and Personalized Medicine, Bioinformatics and Artificial Intelligence

“A thorough, multidisciplinary examination of how genetic editing is revolutionizing medicine and providing fresh hope in the battle against complicated illnesses. . . . An extensive range of chapters on the ethical, legal, and societal consequences of gene editing, with a focus on human rights concerns and the legal frameworks that must adapt to incorporate the impact of gene editing. . . . An essential resource for healthcare experts, researchers, clinicians, and biomedical scientists in the future of healthcare and genetic technology.”—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India